Nierenberg Investment Management Company’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-4,962,856
Closed -$2.43M 37
2023
Q2
$2.43M Buy
4,962,856
+848,382
+21% +$694K 1.66% 7
2023
Q1
$4.77M Buy
4,114,474
+957,302
+30% +$1.75M 3.6% 7
2022
Q4
$8.46M Buy
3,157,172
+1,095,449
+53% +$2.89M 6.37% 6
2022
Q3
$5.9M Buy
2,061,723
+1,276,411
+163% +$5.43M 4.9% 6
2022
Q2
$3.9M Buy
+785,312
New +$4.11M 3.25% 7

Other funds holding CELL

Nierenberg Investment Management Company's CELL Position: Q3 2023 in Review

Nierenberg Investment Management Company sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2023, closing a stake of 4,962,856 shares — an estimated $2.43M sold.

Nierenberg Investment Management Company first reported a position in CELL in Q2 2022 and held it in 5 quarters. The position peaked at $8.46M in Q4 2022. 57 funds tracked by Wall St. Rank hold CELL as of Q3 2023.

  • Nierenberg Investment Management Company reported no remaining PhenomeX Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Nierenberg Investment Management Company sold 4,962,856 PhenomeX Inc. Common Stock shares in Q3 2023, an estimated $2.43M.
  • Nierenberg Investment Management Company first reported a position in PhenomeX Inc. Common Stock in Q2 2022 and held it in 5 quarters.
  • Nierenberg Investment Management Company's PhenomeX Inc. Common Stock position peaked at $8.46M in Q4 2022.
  • 57 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2023.

Based on Nierenberg Investment Management Company's 13F filing for Q3 2023, filed 13 Nov 2023.